CURALINC, LLC – Trademark Portfolio
Entity Type: 16
CURALINC, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include CURALINC, TEXTCOACH, and WORKPLACE DETERMINANTS OF HEALTH. The owner is based in Chicago, IL.
314 W Superior
Suite 601
Chicago, IL 60654
Showing of trademarks Trademarks
Trademark Classifications
CURALINC, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does CURALINC, LLC have?
CURALINC, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 1 cancelled.
What trademark classes does CURALINC, LLC file in?
CURALINC, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 35 (Advertising & Business), Class 38 (Telecommunications). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are CURALINC, LLC's most well-known trademarks?
CURALINC, LLC's registered trademark portfolio includes well-known marks such as CURALINC, TEXTCOACH, and WORKPLACE DETERMINANTS OF HEALTH. These are among 3 currently registered trademarks in the portfolio.
What is CURALINC, LLC's trademark registration success rate?
CURALINC, LLC has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.